Market Trends of France Patient Monitoring Industry
The Neurology Segment is Expected to Show a Healthy Growth in the France Patient Monitoring Market Over the Forecast Period
The neurology segment is expected to witness significant growth in the patient monitoring market over the forecast period owing to the factors such as the rising prevalence of neurological disorders such as Parkinson's, Alzheimer's, dementia, and others, the need for neurological conditions to regularly monitor, and growing company activities in developing monitoring devices that help in monitoring the brain activity.
The rising burden of neurological diseases among the population is the key factor driving the demand for neuromonitoring devices. For instance, according to the Alzheimer's Association 2022, more than 1,175,000 people were living with Alzheimer's disease in 2021, and an estimated 200,000 people are diagnosed with Alzheimer's or another dementia each year in France. Thus, a high number of Alzheimer's patients in France is expected to increase the adoption of patient monitoring devices to track neurological disease conditions, hence propelling the segment's growth.
Furthermore, the increasing product launches in the county increase the availability of neuromonitoring devices in the market, which is expected to boost segment growth. For instance, in March 2022, Braintale, a French MedTech, launched the brainTale-care platform with its modules brainQuant, dedicated to white matter quantification and brainScore-coma, offering the prediction of coma recovery. This launch offers neurologists and resuscitators innovative, non-invasive, clinically verified solutions to enhance the diagnosis, monitoring, and prognosis of the progression of neurological diseases and disorders, greatly influencing the decision-making process to optimize patient treatment.
Moreover, the increasing adoption of various key business strategies among the companies, such as partnerships, agreements, and others, is expected to increase the adoption of patient monitoring devices in the hospital's neurology department, thereby boosting segment growth. For instance, in January 2021, Royal Philips entered a five-year technology and innovation partnership with France-based Rennes University Hospital supporting diagnostic, interventional imaging, and patient monitoring and management. This will help in enhancing clinical pathways and patient experience, particularly for neuro-radiology departments and intensive care units.
Therefore, owing to the factors such as the high burden of neurological diseases, rising company activities, and increasing product launches, the studied segment is expected to grow over the forecast period.
The Cardiology Segment is Expected to Have the Significant Market Share Over the Forecast Period
The cardiology segment is expected to witness a significant market share in the patient monitoring market in France over the forecast period owing to the factors such as the rising burden of cardiovascular disease, its risk-associated factors, and the growing adoption of cardiac monitoring devices. Cardiac monitoring refers to continuous or intermittent monitoring of heart activity with the assessment of the patient's condition relative to their cardiac rhythm. Additional monitoring components allow cardiovascular pressures and cardiac output to be monitored and displayed as required for patient diagnosis and treatment.
The rising prevalence of hypertension, stroke, diabetes, obesity and other cardiovascular diseases is the key factor driving the demand for cardiac patient monitoring equipment, hence bolstering segment growth. For instance, an article published in Dovepress in January 2022 observed that the incidence of myocardial infarction among the population living in France was expected to double by 2035. In addition, younger women are more expected to suffer from MI than men. Thus, the expected increase in the population suffering from heart diseases is anticipated to fuel the demand for cardiac monitoring devices to further reduces the risk of heart failure, hence propelling the segment growth.
Additionally, according to an article published in PLOS One in June 2021, obesity was considered a significant public health problem in France as it is a risk factor for chronic diseases, such as diabetes and hypertension, etc., which in turn has substantial psychological and social consequences. Thus, the increasing burden of obesity is likely to develop various heart diseases and may lead to the accumulation of lipids in the arteries, decreased cardiac rhythms, and other problems. This is anticipated to increase the demand for regular monitoring of the heart condition, hence bolstering segment growth.
Moreover, the rising product launches for monitoring as well as early detection of heart conditions are also expected to bolster market growth. For instance, in September 2021, Withing launched a cardiac monitoring smartwatch, ScanWatch Horizon, in France, which includes a slew of heart-health monitoring features such as heart rate, ECG, breathing disturbances, blood oxygen levels, sleep, and physical activity tracking. This watch enables the patient to identify heart rhythms, as well as the ECG feature to help detect atrial fibrillation.
Therefore, owing to the factors such as the rising burden of obesity, diabetes, and cardiovascular diseases and increasing product launches, the studied segment is expected to grow over the forecast period.
